Wojciech Szubert

Wojciech Szubert


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Journal of Biomechanics
Verified
Journal Article
Closed access
PRPiotr Reorowicz
Piotr Reorowicz
DODamian Obidowski
Damian Obidowski
PKPrzemyslaw Klosinski
Przemyslaw Klosinski
WSWojciech Szubert
Wojciech Szubert
LSLudomir Stefanczyk
Ludomir Stefanczyk
Krzysztof Stanislaw JozwikKrzysztof Stanislaw Jozwik
Krzysztof Stanislaw Jozwik

1 September 2017 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
ASAgnieszka Słowik
Agnieszka Słowik
MWMarcin Wnuk
Marcin Wnuk
PBPaweł Brzegowy
Paweł Brzegowy
JCJoanna Chrzanowska-Waśko
Joanna Chrzanowska-Waśko
AGAleksandra Golenia
Aleksandra Golenia
TPTadeusz J. Popiela
Tadeusz J. Popiela
Mechanical thrombectomy (MT) is not reimbursed by the Polish public health system. We present a description of 5 years of experience with MT in acute stroke in Comprehensive Stroke Centers (CSCs) in Poland. We retrospectively analyzed the results of a structured questionnaire from 23 out of 25 identified CSCs and 22 data sets that include 61 clinical, radiological and outcome measures. Most of the CSCs (74%) were founded at University Hospitals and most (65.2%) work round the clock. In 78.3% of them, the working teams are composed of neurologists and neuro-radiologists. All CSCs perform CT and angio-CT before MT. In total 586 patients were subjected to MT and data from 531 of them were analyzed. Mean time laps from stroke onset to groin puncture was 250±99min. 90.3% of the studied patients had MT within 6h from stroke onset; 59.3% of them were treated with IV rt-PA prior to MT; 15.1% had IA rt-PA during MT and 4.7% - emergent stenting of a large vessel. M1 of MCA was occluded in 47.8% of cases. The Solitaire device was used in 53% of cases. Successful recanalization (TICI2b-TICI3) was achieved in 64.6% of cases and 53.4% of patients did not experience hemorrhagic transformation. Clinical improvement on discharge was noticed in 53.7% of cases, futile recanalization - in 30.7%, mRS of 0-2 - in 31.4% and mRS of 6 in 22% of cases. Our results can help harmonize standards for MT in Poland according to international guidelines.

11 December 2025 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
AZAnna Ziętarska
Anna Ziętarska
ADAdam Dobek
Adam Dobek
Piotr BiałekPiotr Białek
Piotr Białek
WSWojciech Szubert
Wojciech Szubert
Sebastian MajewskiSebastian Majewski
Sebastian Majewski
LSLudomir Stefańczyk
Ludomir Stefańczyk
Haemoptysis arises from diverse respiratory diseases and may involve a broad spectrum of thoracic vessels. Arterial embolisation (AE) is an effective, repeatable, minimally invasive treatment option for life-threatening haemoptysis. This case series included 10 patients (mean age 34 years; six males; five with cystic fibrosis) who underwent 17 AE procedures for life-threatening haemoptysis between January 2018 and September 2025. The study assessed the role of wide-field computed tomography angiography (CTA), extending from the thoracic inlet to L2, in preprocedural planning, bleeding localisation and detection of systemic collaterals. CTA accurately predicted the culprit region in 16 out of 17 procedures. Non-bronchial systemic arteries were identified in 6 out of 10 patients, consistent with previous reports. CTA showed strong concordance with angiography and enabled the detection of uncommon collaterals, including subclavian and phrenic branches. Recurrence of hemoptysis occurred in one patient during follow-up; however, three patients were lost to follow-up. Wide-field CTA enhances the identification of systemic feeders and supports procedural planning, potentially reducing recurrence associated with missed culprit vessels. AE remains a valuable option for haemoptysis control in cystic fibrosis, with outcomes further improved following initiation of CFTR modulators. The small sample size and incomplete follow-up limit generalisability, but findings highlight the importance of CTA in guiding AE and improving clinical outcomes.


26 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
ADAdam Dobek
Adam Dobek
WSWojciech Szubert
Wojciech Szubert
KKKatarzyna Emilia Kurzyk
Katarzyna Emilia Kurzyk
KZKarol Zaczkowski
Karol Zaczkowski
KWKarol Wiśniewski
Karol Wiśniewski
LSLudomir Stefańczyk
Ludomir Stefańczyk
Introduction: Cerebral arteriovenous malformations (CAVMs) are rare, with an estimated prevalence of 0.01%. Symptoms typically present in adults under 40, often beginning with hemorrhage in 61% of cases. The annual risk of hemorrhage is between 2–4%, with a mortality rate of 10%, and 50% of survivors may experience permanent neurological deficits. Embolization can induce changes in the angioarchitecture of the affected vessels. Our case uniquely demonstrates a morphological alteration in the carotid artery (CA) and its primary branches, associated with the presence of a CAVM. Detailed Case Presentation: A 52-year-old patient presented to the Emergency Department with weakness, shortness of breath, dizziness, nausea, and vomiting that began earlier that morning. Clinical and radiological evaluations suggested acute bleeding from a ruptured CAVM. The patient was admitted for digital subtraction angiography (DSA) and potential embolization. DSA confirmed the presence of a CAVM, supplied by the middle meningeal and occipital arteries, with distortion of the left CA angioarchitecture. Selective catheterization and embolization using Onyx 18 were successfully performed. After receiving supportive treatment, the patient was discharged in good condition. A follow-up CT scan three months later showed complete resolution of the brain pathologies. A repeat angiogram revealed no recanalization of the CAVM, with normalization of the CA and its branches. The patient is currently asymptomatic. Conclusions: Detection of pathological changes in the head and neck arteries linked to CAVM can predict rupture risk and complicate endovascular access. Identifying these changes early warrants consideration of interventions to prevent hemorrhage, though alternative access routes or strategies may be needed for safe, effective treatment.